Chemical company Perstorp is investing in upgrading its Caprolactone business by constructing new equipment using state-of-the-art materials. The investment aims to future-proof production and increase security of supply. The project, which includes installing a new peracetic acid still and new reactors, is expected to be completed in the second half of 2019. Perstorp sees the Caprolactone market as strategic and important, and the investment is part of the company's long-term commitment to the industry.
Perstorp is securing the future of its Caprolactone business through a significant investment to upgrade its original monomer plant. The new equipment will be constructed using state of the art materials and the investment will future proof the production and even further increase security of supply.
The Caprolactone market is strategic and important to Perstorp. This investment is one step further in the company’s long term commitment to the industry.
The project was initiated and kicked off in the beginning of 2017 and construction phase of the new parts of the plant will start in the New Year. The replacement will be conducted in a way that does not impact current production. The plant upgrade consists of installing a new peracetic acid still and new reactors on stream 1, which was originally built in 1998. The project is expected to be complete in the second half of 2019.
“The Capa™ business is one of our strategic areas and we do see a strong market demand of Capa™ products. Through this investment we are strengthening our position as a reliable leading partner”, says Marie Grönborg, Executive Vice President at Perstorp.